InvestSMART

Insights

Subscribe to our Free Insights Newsletter today

Pre-emptive healthcare with CRISPR

After the Nobel Prize in Chemistry was awarded to two scientists for their work on CRISPR, Steve Sammartino explains the significance of CRISPR's ability to edit DNA and why thoughtful regulation should be used to unleash its potential in a fair way.

13 Oct 2020
·
Article comments

IPO Watch: Zebit – 'Amazon for the under-served meets Afterpay'

Ahead of its listing on the ASX, Alex Gluyas catches up with the CEO of Zebit, Marc Schneider, who explains the company's unique e-commerce platform with a built-in buy-now-pay-later offering, how it's managing the risk of serving credit-challenged customers in the US, and why it's protected from the crowded US buy-now-pay-later space.

13 Oct 2020
·
Article comments

Home - the final frontier

Following the launch of Amazon's Always Home indoor drone, Steve Sammartino explores the reasons why Big Tech are only about to get stronger, as Amazon is now exploring the final commercial frontier – your home.

29 Sep 2020
·
Article comments

How to navigate COVID-led changes to the investing landscape

If the post-COVID environment truly is an inflection point for the local and global economies, then one of the challenges for investors is looking beyond the 'bubble' that the once-in-a-lifetime pandemic has created. And, while this theme may throw up a cauldron of investing opportunities, it also throws up risks, making the need for diversification within the post-COVID environment an essential part of further investing.

24 Sep 2020
·
Article comments

Has buy now pay later's day of reckoning arrived?

The news of PayPal's arrival on the buy now pay later scene (BNPL) has been accompanied by a swift sell-off in ASX BNPL stocks. Alex Gluyas explores why some investment banks are seeing this as the sector's reckoning and why other pundits believe there's plenty of juice left in the BNPL ride.

22 Sep 2020
·
Article comments

929 - 944 of 97640 results

Page 59 of 6103